• 한국염색가공학회지
• /
• 제19권1호
• /
• pp.24-30
• /
• 2007

Heat storage/release system in textile is a useful tool to increase energy efficiency and enhance comfortable microclimate of clothing. Phase change materials(PCM) are used in regulating storage and release properties of thermal energy. To investigate the temperature regulating ability of fabrics with PCM microcapsule(PCMMc), Nylon fabrics were coated with PCMMc via wet processing and they were characterized by SEM, DSC and infrared thermal analyzer. Also, water moisture transpiration, water penetration resistance, peel strength and washing durability of the fabrics were assessed. The water vapor permeation and water penetration resistance decreased with increasing PCMMc content. In DSC analysis, it can be seen that the microencapsulated fabric showed both exothermic md endothermic phenomena at specific temperature. Peel strength was decreased with increasing PCMMc content.

• Food Science and Biotechnology
• /
• 제15권6호
• /
• pp.902-907
• /
• 2006

Freeze dried crude bacteriocin was encapsulated within an acid-soluble coating material, Eudragit EPO, using a surface modification technique through a hybridization system. The pH and titratable acidity of control yoghurt were 3.92 and 1.56%, respectively, after 24 hr of fermentation at $42^{\circ}C$, whereas yoghurt containing 500 AU/mL encapsulated bacteriocin exhibited a higher pH (4.37) and lower titratable acidity (1.2%). Yoghurt containing encapsulated bacteriocin had significantly lower titratable acidity when the duration of fermentation (to pH 4.5) and subsequent refrigerated storage ($4^{\circ}C$) was longer than 20 days. There were no significant differences in the viability of lactic acid bacteria after 15 hr of fermentation. This suggests that microencapsulated bacteriocin has the potential to control the excessive growth of yoghurt starters caused by temperature abuse or post-acidification.

• Asian-Australasian Journal of Animal Sciences
• /
• 제15권4호
• /
• pp.596-601
• /
• 2002

The present study was designed to examine the effect of ozone treatment in microencapsulated ${\beta}$-galactosidase on inactivation of the enzyme and sterilization of microorganism. The efficiency was the highest as 78.4% when the ratio of polyglycerol monostearate (PGMS) was 15:1. Activities of lactase remaining outside the capsule were affected by ozone treatment. With the increase of ozone concentration and duration of ozone treatment, the activity reduced significantly. In sensory aspect, with 2% microcapsule addition, no significant difference in sweetness was found compared with a market milk during 12 d storage. Above result indicated that the additional washing process of lactase was not necessary to inactivate the residual enzyme. In a subsequent study, the vegetative cells of microorganisms were completely killed with 10 ppm for 10 min treatment by ozone. The present study provides evidence that ozone treatment can be used as an inactivation and a sterilization process. In addition, these results suggest that acceptable milk products containing lactase microcapsules made by PGMS can be prepared with ozone treatment.

• 한국수소및신에너지학회논문집
• /
• 제1권1호
• /
• pp.31-39
• /
• 1989

Although it has been well known that many metal hydrides are promising to use for hydrogen storage and other applications, some difficulties still remain. Metal hydrides, particularly in powder form, have very poor thermal conductivity. The hydrogen storage alloys degrade intrinsically or extrinsically during repeated hydriding and dehydriding. Elimination of these problems is very important in the practical applications. In order to prevent degradation and to improve the thermal conductivity, the hydrogen storage characteristics of rare-earth type alloy encapsulated with Cu or Ni by means of chemical plating have been investigated. No changes has occured in hydrogen absorption capacity and equilibrium pressure even though the alloy powder is microencapsulated. The first hydrogen absorption rate of the alloy encapsulated increased considerably comparing to uncapsulated sample. In the case of encapsulating the fine powder ($>10{\mu}m$) and subsequent compacting by $8ton/cm^2$, shape of compact is maintained regardless of hydriding and dehydriding. The degree of degradation of the alloy caused by impurity gas of CO or $O_2$ was decreased prominently by encapsulation.

• Asian-Australasian Journal of Animal Sciences
• /
• 제15권12호
• /
• pp.1808-1812
• /
• 2002

The present study was carried out to examine the efficiency of microcapsules and a stability of lactase in vitro in the simulated gastric and intestinal conditions. As a coating materials, medium-chain triacylglycerol (MCT) and polyglycerol monostearate (PGMS) were used. The highest efficiency of microencapsulation was found in the ratio of 15:1 as coating to core material with both MCT (91.5%) and PGMS (75.4%). In a subsequent experiment, lactose content was measured to study a microcapsule stability. Lysis of microcapsules made by MCT in simulated gastric fluid was proportionally increased such as 3% in pH 5 and 11% in pH 2 for 20 min incubation. In the case of PGMS microcapsulation, 11-13% of lactose was hydrolyzed at 20 min in all pHs and also very little amount (less than 3%) of lactose was hydrolyzed after 20 min in all pHs. The highest percentages of lactose hydrolysis in MCT and PGMS microcapsules were 68.8 and 60.8% in pHs 7 and 8 during 60 min, respectively. Based on our data, the lactase microcapsules seemed to be stable when they stay in the stomach, and hydrolyzed rapidly in small intestine where the bile acid was excreted.

• Asian-Australasian Journal of Animal Sciences
• /
• 제16권8호
• /
• pp.1205-1211
• /
• 2003

This study was designed to examine the effect of microencapsulated iron-fortified Cheddar cheese and L-ascorbic acid as a bioavailable helper of iron on chemical and sensory aspects. Coating material was PGMS, and ferric ammonium sulfate and Lascorbic acid were selected as core materials. The highest efficiency of microencapsulation of iron and L-ascorbic acid were 72 and 94%, respectively, with 5:1:50 ratio (w/w/v) as coating to core material to distilled water. TBA absorbance was significantly lower in microencapsulated treatments than those in uncapsulated treatments during ripening. The productions of short-chain free fatty acid and neutral volatile compound were not significantly different among treatments during ripening periods. In sensory aspects, bitterness, astrigency and sourness were higher in Cheddar cheese fortified with microencapsulated iron and uncapsulated L-ascorbic acid than others. The present study indicated that fortification of iron as well as L-ascorbic acid did not show any defect problem to Cheddar cheese, and suggested the possibility of iron fortification of Cheddar cheese.

• Biotechnology and Bioprocess Engineering:BBE
• /
• 제2권2호
• /
• pp.77-81
• /
• 1997

Removal of nitrogen compound from waste water is essential and often accomplished by biological process. To prevent washout and to develop an efficient bioreactor, immobilization of sutibal microorganisms could be sensible approach. Strains and permeabilized cell encapsulated in cellulose nitrate microcapsules and immobilized on polystyrene films were prepared by the method described in the previous study. In the wastewater treatment system, nitrification of ammonia component is generally known as rate controlling step. To enhance the rate of nitrification, firstly nitrifying strains Nitrosomonas europaea(IFO14298), are permeabilized chemically, and immobilized on polystyrene films and secondly oxidation rates of strain system and permeabilized strain system are compared in the same condition. with 30 minute permeabilized cells, it took about 25 hours to oxidize 70% of ammonia in the solution, while it took about 40 hours to treat same amount of ammonia with untreated cells. All the immobilization procedures did not harm to the enzyme activity and no mass transfer resistance through the capsule well was shown. In the durability test of immobilized system, the system showed considerable activity for the repeated operation for 90 days. With these results, the system developed in this study showed the possibility to be used in the actual waste water treatment system.

• 한국식품과학회지
• /
• 제31권2호
• /
• pp.280-284
• /
• 1999

Ascorbic acid의 불안정성을 극복하기 위하여, 탈수화/재수화의 방법을 이용하여 soybean phosphatidyl choline으로 제조한 리포솜에 ascorbic acid를 미세캡슐화하였다. Ascorbic acid는 46.8%의 효율로 리포솜내에 포집되었다. 리포솜 내에서의 ascorbic acid는 수용액에서보다 안정성이 매우 증대되었다. 예로 pH 5.0의 acetate buffer에서의 ascorbic acid는 7일 경과 후에 대부분이 산화되지만, 같은 조건에서 리포솜에 미세캡슐화되었을 경우는 40일이 경과하여도 22.8%가 환원된 상태를 유지하였다. 이러한 결과는 리포솜으로 ascorbic acid를 미세캡슐화하면 저장 기간을 향상시키는 보호 수단으로 이용될 수 있음을 의미한다.

• 한국정보디스플레이학회:학술대회논문집
• /
• 한국정보디스플레이학회 2005년도 International Meeting on Information Displayvol.I
• /
• pp.464-467
• /
• 2005

In this paper, we present techniques to manufacture color electronic ink for multi-color electrophoretic display implementation. The charged color pigments have been prepared to have superior affinity for dielectric fluid. White $TiO_2$ nanoparticles were modified with poly(methyl methacrylate) copolymer for a microencapsulated electrophoretic display system, in order to reduce the density mismatch between nanoparticles and dielectric medium. These color balls and white pigment particle suspensions were microencapsulated through the typical microencapsulation technique. We fabricate the microcapsules to the single layer on flexible ITO substrate to test the multi-color electrophoretic display application.

• Archives of Pharmacal Research
• /
• 제25권5호
• /
• pp.572-584
• /
• 2002

Rapid development in molecular biology and recent advancement in recombinant technology increase identification and commercialization of potential protein drugs. Traditional forms of administrations for the peptide and protein drugs often rely on their parenteral injection, since the bioavailability of these therapeutic agents is poor when administered nonparenterally. Tremendous efforts by numerous investigators in the world have been put to improve protein formulations and as a result, a few successful formulations have been developed including sustained-release human growth hormone. For a promising protein delivery technology, efficacy and safety are the first requirement to meet. However, these systems still require periodic injection and increase the incidence of patient compliance. The development of an oral dosage form that improves the absorption of peptide and especially protein drugs is the most desirable formulation but one of the greatest challenges in the pharmaceutical field. The major barriers to developing oral formulations for peptides and proteins are metabolic enzymes and impermeable mucosal tissues in the intestine. Furthermore, chemical and conformational instability of protein drugs is not a small issue in protein pharmaceuticals. Conventional pharmaceutical approaches to address these barriers, which have been successful with traditional organic drug molecules, have not been effective for peptide and protein formulations. It is likely that effective oral formulations for peptides and proteins will remain highly compound specific. A number of innovative oral drug delivery approaches have been recently developed, including the drug entrapment within small vesicles or their passage through the intestinal paracellular pathway. This review provides a summary of the novel approaches currently in progress in the protein oral delivery followed by factors affecting protein oral absorption.